Your session is about to expire
← Back to Search
Mesh
Prevention of Parastomal Hernia by Mesh Placement
N/A
Waitlist Available
Led By Murugesan Manoharan, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 months
Awards & highlights
No Placebo-Only Group
Summary
Concurrent placement of a mesh during formation of ileal conduit will decrease the incidence of parastomal hernia and associated complications.
Eligible Conditions
- Parastomal Hernia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 60 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Rate of Reduction of the Incidence of Parastomal Hernia
Secondary study objectives
Number of Participants Who Develop Mesh Related Complications
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Group 1 - Ideal Conduit No MeshActive Control1 Intervention
No mesh will be placed at the time of radical cystectomy and ileal conduit.
Group II: Group 2 - Ileal Conduit with MeshActive Control1 Intervention
Ethicon Physiomesh will be placed at the time of radical cystectomy and ileal conduit.
Find a Location
Who is running the clinical trial?
Ethicon, Inc.Industry Sponsor
92 Previous Clinical Trials
62,209 Total Patients Enrolled
University of MiamiLead Sponsor
955 Previous Clinical Trials
428,841 Total Patients Enrolled
Murugesan Manoharan, MDPrincipal InvestigatorUniversity of Miami